You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Clinical and demographic characteristics of HIV subjects in study cohorts

From: Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors

Characteristic Initial cohort (n=17) Validation cohort (n=15)
Age (years)* 45 (42–50) 45 (43–50)
Gender (male) 12 (60%) 15 (83%)
Race (African American) 15 (75%) 9 (50%)
BMI 23.7 (22.9-24.7) 23.9 (22.7-27.2)
HCV seropositive 7 (41%) 15 (100%)
Time on ART (months)* 30 (13–50) 36 (16–50)
CD4 T-cell count (cells/ul)* 267 (107–399) 213 (126–293)
Nadir CD4 T-cell count (cells/ul)* 58 (18–136) 53 (9–132)
Plasma HIV RNA (copies/ml)* 69 (50–181) 50 (50–88)
Total Bilirubin (mg/dL)* 0.6 (0.4-0.9) 0.6 (0.4-0.9)
ALT (IU/L)* 31 (23–77) 27 (20–38)
AST (IU/L)* 36 (25–59) 33 (24–52)
Alkaline Phosphatase (IU/L)* 96 (81–128) 88 (80–128)
Albumin (g/dL)* 4.0 (3.7-4.5) 4.0 (3.7-4.4)
  1. * Median (IQR).